WORLDSymposium 2023 Roscoe O. Brady Award was presented to William A. Gahl, MD, PhD, on Wednesday, February 22, at 7:30 AM EST, followed by a scientific presentation by Dr. Gahl: Pursuing Advances in Rare and Undiagnosed Diseases. View details.
The WORLDSymposium New Treatment Award for 2023 was presented to Sanofi for olipudase alfa-rpcp (Xenpozyme™) More details.
Dr. Peter Marks’ Keynote Address: Taking Gene Therapy to the Next Level, was on Friday, February 24, 2023 at 7:30 AM EST. Read speaker bio.
WORLDSymposium 2023 Patient Advocate Leader (PAL) Award was received by Christine Waggoner on Thursday, February 23, 2023. Christine founded the Cure GM1 Foundation in April 2015 in honor of her daughter Iris and all those affected by GM1 gangliosidosis. More details.
WORLDSymposium was pleased to announce the recipients of the 2023 Young Investigator Awards on Tuesday, February 23, 2023. More details.
19 Satellite symposia were held from Wednesday, February 22, 2023 to Saturday, February 25, 2023 Click here for the full schedule.
WORLDSymposium 2023 had 460 scientific abstracts presented at eight (8) separate poster sessions. View 2023 Poster List.
WORLDSymposium 2023 attracted over 30 Exhibitors and 11 Patient Advocate Groups. View 2023 Exhibitor List.
After the presentation of the Innovation Award, the formal scientific sessions of WORLDSymposium 2023 officially began with presentations on laboratory research for lysosomal disease. Presentations during the Basic Science sessions are designed to improve our understanding or prediction of the phenomena involved in lysosomal pathology at a molecular, cellular, and animal model level in order to forwardly think about diagnosis and treatment of lysosomal conditions. View full program.
For the eleventh consecutive year, WORLDSymposium™ began with “Emerging Trends”. This 2-hour CME/CE course provides a state-of-the-art update for experts working in lysosomal biology and lysosomal diseases. More details.
The goal of the 2023 Symposium was to address the tremendous opportunity for Precision Medicine in lysosomal diseases. Over the past decade there has been much discussion about “Precision Medicine” and its use for many different diseases, including lysosomal disorders. Although it is not a new concept, more and more researchers and clinicians are recognizing that precision medicine must guide the path forward for patients with lysosomal diseases. More details.
The inaugural Speed Mentoring Event was open to all registered WORLDSymposium attendees as part of the conference registration. It was a great success with 34 Mentors and over 70 individuals who received valuable insights and career advice from lysosomal disease experts from around the globe.